Physician profile
David Hinkle Lamb
NPI 1215961842
$6,834.56
in general payments reported to CMS, 2019-2025
25 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,258 · 2020: $661 · 2021: $619 · 2022: $1,547 · 2023: $853 · 2024: $632 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Travel and Lodging: $79.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.01 |
| Travel and Lodging | $79.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,264.19 | 2019-2025 | Titan, Speedicath |
| Boston Scientific Corporation | $1,387.02 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $433.81 | 2023-2025 | |
| Teleflex LLC | $352.43 | 2021-2022 | |
| Olympus America INC. | $344.21 | 2022-2025 | Itind System |
| Medtronic, INC. | $232.08 | 2022-2024 | Interstim |
| Photocure INC | $164.05 | 2019 | |
| Calyxo, INC. | $113.80 | 2024 | Cvac Aspiration System |
| Astellas Pharma US INC | $109.51 | 2019-2020 | |
| Innovation Technologies INC | $64.53 | 2024-2025 | Irrisept |
| Janssen Biotech, INC. | $61.67 | 2019 | |
| Rochester Medical Corporation | $54.97 | 2021-2022 | |
| Medtronic USA, INC. | $48.82 | 2019 | |
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Laborie Medical Technologies Corp. | $22.86 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $17.41 | 2022 | |
| Heron Therapeutics, INC. | $17.27 | 2021 | |
| Antares Pharma, INC. | $15.25 | 2024 | Xyosted |
| Procept Biorobotics Corporation | $15.23 | 2024 | Aquabeam System |
| Novartis Pharmaceuticals Corporation | $15.19 | 2025 | |
| Ambu INC. | $14.69 | 2022 | |
| Pfizer INC. | $12.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.67 | 2019 | |
| Hollister Incorporated | $12.53 | 2022 | |
| Endo Pharmaceuticals INC. | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.